← Leaderboards
Jonathan A Garlick
State University New York Stony Brook
$6,684,830
Attributed
$8,306,709
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2005–15$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$8,306,709 · 4
By mechanism
R01$5,873,891 · 3
DP3$2,432,818 · 1
Top collaborators
- David J Mooney1 shared
- Aristidis Veves1 shared
Most similar at State University New York Stony Brook
Same institution · by research overlap
- Christopher W Cutler$6,543,935
- Ghassan J Samara$124,520
- Joshua Rest$926,537
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypeEpitheliumKeratinocyteFibroblastsCellsNovel StrategiesInsightMediatingPatternLinkNew TechnologyGenerationsBaseFutureSourceTissuesComplexTransplantationIn VivoCuesBehaviorEmbryonic Stem CellBasement MembraneDentistry
Grant awards (17)
Role of Macrophages in Impaired Wound Healing in Type 1 Diabetes$2,432,818
DP3 · FY2015 · DK
iPSC-derived Repair-Responsive Fibroblasts to Heal Diabetic Foot Ulcers$651,584
R01 · FY2015 · DK · contact PI
iPSC-derived Repair-Responsive Fibroblasts to Heal Diabetic Foot Ulcers$656,135
R01 · FY2014 · DK · contact PI
iPSC-derived Repair-Responsive Fibroblasts to Heal Diabetic Foot Ulcers$608,831
R01 · FY2013 · DK · contact PI
iPSC-derived Repair-Responsive Fibroblasts to Heal Diabetic Foot Ulcers$678,762
R01 · FY2012 · DK · contact PI
Bioengineered Oral Mucosa from Embryonic Stem Cells for Regenerative Medicine$301,245
R01 · FY2011 · DE · contact PI
Bioengineered Oral Mucosa from Embryonic Stem Cells for Regenerative Medicine$310,563
R01 · FY2010 · DE · contact PI
Bioengineered Oral Mucosa from Embryonic Stem Cells for Regenerative Medicine$364,775
R01 · FY2009 · DE · contact PI
Bioengineered Oral Mucosa from Embryonic Stem Cells for Regenerative Medicine$313,701
R01 · FY2009 · DE · contact PI
Bioengineered Oral Mucosa from Embryonic Stem Cells for Regenerative Medicine$352,913
R01 · FY2008 · DE · contact PI
Bioengineered Oral Mucosa from Embryonic Stem Cells for Regenerative Medicine$356,839
R01 · FY2007 · DE · contact PI
PATHWAYS AND MECHANISMS CONTROLLING EARLY ORAL NEOPLASIA$266,096
R01 · FY2005 · DE
PATHWAYS AND MECHANISMS CONTROLLING EARLY ORAL NEOPLASIA$162,895
R01 · FY2004 · DE
PATHWAYS AND MECHANISMS CONTROLLING EARLY ORAL NEOPLASIA$89,925
R01 · FY2004 · DE
PATHWAYS AND MECHANISMS CONTROLLING EARLY ORAL NEOPLASIA$244,125
R01 · FY2003 · DE
PATHWAYS AND MECHANISMS CONTROLLING EARLY ORAL NEOPLASIA$244,125
R01 · FY2002 · DE
PATHWAYS AND MECHANISMS CONTROLLING EARLY ORAL NEOPLASIA$271,377
R01 · FY2001 · DE